World Anti‐Doping Agency
Total Page：16
File Type：pdf, Size：1020Kb
World Anti‐Doping Agency Independent Observer Report Pan American Games Guadalajara, Mexico October 14‐30, 2011 Table of Contents Table of Contents ................................................................................................................................... 2 Acknowledgements ................................................................................................................................ 3 PASO/WADA Agreement and Compliance ............................................................................................. 4 The Mission ............................................................................................................................................ 4 Objective ............................................................................................................................................ 4 The IO Team ....................................................................................................................................... 4 Methodology ...................................................................................................................................... 4 Observations .......................................................................................................................................... 5 Doping Control ................................................................................................................................... 5 Training and Education of Doping Control Personnel .................................................................... 5 Doping Control Manual .................................................................................................................. 6 Out‐of‐Competition Testing ........................................................................................................... 8 Preparation for Sample Collection Process .................................................................................. 10 Notification ................................................................................................................................... 12 Urine Sample Collection Procedure ............................................................................................. 13 Blood Sample Collection Procedure ............................................................................................. 13 Security/Post‐Test Administration ............................................................................................... 14 Transport and Receipt of Samples ............................................................................................... 14 Therapeutic Use Exemptions ........................................................................................................... 15 Laboratory Sample Analysis ............................................................................................................. 16 Results Management ....................................................................................................................... 16 Other Issues ...................................................................................................................................... 17 ADAMS ......................................................................................................................................... 17 Conflict of Interest ........................................................................................................................ 17 Confidentiality .............................................................................................................................. 18 Educational Material .................................................................................................................... 18 Contaminated of Meat with Clenbuterol ..................................................................................... 19 Recommendations ............................................................................................................................... 19 2 Acknowledgements The XVI Pan American Games held in Guadalajara, Mexico, 14-29 October 2011 included a doping control program that was the largest in the history of the Games. A large number of urine samples were collected from the more than 6,000 athletes participating in the Games and blood samples were collected for the first time at the Pan American Games. For many of the athletes, this was their first experience with doping control, especially with blood sample collection, and we commend the Pan American Sports Organization (PASO) for conducting their doping control program with the professionalism and effectiveness demonstrated throughout the Games. In order to fulfill its mandate, the Independent Observer (IO) Team relied on the support and assistance of many people during the Games. First and foremost, we would like to thank the Pan American Sports Organization (PASO) for their invitation to attend this event and to the Chair of the PASO Medical Commission (MC), Prof. Eduardo De Rose, for the support showed to the role of the IO Team. We would also like to thank the individual members of the PASO MC for their cooperation and open mindedness. The interaction between the PASO MC and the IO Team was fruitful and appreciated. We would also like to thank the Doping Control Services of Pan American Games for their hard work during the Games, even taking in consideration the problems that occurred at the beginning of the anti-doping program due to the lack of experience of some personnel. Most challenges seemed to be related to the Local Organizing Committee, but the PASO MC took the right measures to solve the more critical issues. The doping control staff that we met at every level was committed to doping free sport and the message of fair play. Finally, we wish to acknowledge the athletes who participated cleanly in the XVI Pan American Games. The way the athletes participated in WADA’s Outreach Program during the Games represented the best example of their involvement to achieve the goal – Play True. We encourage these athletes to continue to demand that their anti-doping organizations (International Federations and National Anti-Doping Organizations) support doping free sport without conflicts of interest. The Independent Observer Team XVI Pan American Games Guadalajara, Mexico October 2011 3 PASO/WADA Agreement and Compliance An Agreement was signed between the World Anti-Doping Agency (WADA) and PASO to permit an IO Team to observe all aspects of the doping control program for the XVI Pan American Games. The terms of the Agreement were met with full cooperation from PASO, who ensured that the IO Team had full access to any and all resources to fulfill its mission, even taking into consideration some logistical problems that occurred in the first week of the IO Team activities. The PASO anti-doping rules were covered through Section XII of their Statutes and the accompanying Doping Control Manual, which was deemed “an essential component and compliment to the PASO Statutes and the Regulations of the Pan American Games”. These Rules were accepted, for the purposes of this mission and Report, as meeting the obligations of PASO to adopt and implement rules in line with the World Anti-Doping Code. The Mission Objective The aim of the WADA IO/Audit program is to complement effective doping control programs during Major Games or sporting events. The observation/audit shall provide a system of evaluation to assess whether or not procedures conform to the existing documented standards and rules and to provide on-site advice, guidance or assistance as may be needed. If non-conformities are identified, the need for corrective action can be suggested and improvements can be made in a timely manner. The IO Team The WADA IO Team for the XVI Pan American Games consisted of: Luis Horta – President, Anti-Doping Authority of Portugal, (Portugal) – Chair Anne Cappelen – Director, Systems and Results Management, Anti-Doping Norway (Norway) David Julien - Manager, Program Development, WADA Staff (Canada) Methodology The terms of the Agreement between WADA and PASO established the base guidelines for the role of the IO Team at the XVI Pan American Games. The PASO MC provided for complete access to the IO Team throughout the Games, thus ensuring a collaborative approach to guarantee the most effective doping control program. The IO Team attempted to observe all aspects of the doping control program at the Games, including: In- and out-of-competition testing; Athlete selection process; Athlete notification and chaperoning; Urine and blood sample collection procedures; 4 Chain of custody procedures; Delivery of samples to the laboratory; Laboratory activities; All doping control documentation; Therapeutic Use Exemption Committee meetings; Use of ADAMS during the Games; Results management process; and Possible hearings conducted during the period of the mission. The IO Team attended all PASO MC meetings. At these meetings the IO Chair was able to listen to MC Members discuss what they observed in the field and any other anti- doping issues that arose. In addition, the IO Chair presented a verbal report on the key issues that the IO Team observed the previous day. Daily written reports were provided to the Chair of the PASO MC. These reports included the information that the IO Chair verbally reported to the MC, in addition to other issues that the IO Team felt was important to report. It is worth mentioning